                               SEQUENCE LISTING	

<110> CENTRILLION TECHNOLOGY HOLDING CORPORATION
 
<120> METHODS AND SYSTEMS FOR SEQUENCING NUCLEIC ACIDS

<130> 38558-705.601

<140> PCT/US2012/000185
<141> 2012-04-02

<150> 13/153,218
<151> 2011-06-03

<150> 61/489,662
<151> 2011-05-24

<150> 61/477,173
<151> 2011-04-20

<150> 61/470,497
<151> 2011-04-01

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
ggctctc                                                                  7


<210> 2
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
ggctctcaag ggca                                                         14


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
ggctctcaag ggcatcggtc g                                                 21


<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
ggctctcaag ggcatcggtc gacgc                                             25


<210> 5
<211> 35
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ggctctcaag ggcatcggtc gacgctctcc cttat                                  35


<210> 6
<211> 40
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac                             40


<210> 7
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac tcctgc                      46


<210> 8
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac tcctgcatta ggaag            55


<210> 9
<211> 63
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac tcctgcatta ggaagcagcc       60

cag                                                                     63


<210> 10
<211> 76
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac tcctgcatta ggaagcagcc       60

cagtagtagg ttgagg                                                       76


<210> 11
<211> 82
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac tcctgcatta ggaagcagcc       60

cagtagtagg ttgaggccgt tg                                                82


<210> 12
<211> 102
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 12
ggctctcaag ggcatcggtc gacgctctcc cttatgcgac tcctgcatta ggaagcagcc       60

cagtagtagg ttgaggccgt tgagcaccgc cgccgcaagg aa                         102


